VUMC in the news: COVID experts featured at CNN, NPR and more

The Daily Beast reporter Rachel Cohen, CNN health and wellness reporter Sandee LaMonte, Healthline reporter LIz Pratt, CNN’s Erica Hill, CNN senior medical correspondent Elizabeth Cohen, Radio Health Journal executive producer Reed Pence, Parade magazine reporter Korin Miller, NBC News reporter Erika Edwards, CNN reporter Gina Yu, Under Armour’s publication MyFitnessPal, Huffington Post, The Dallas Morning News reporter Allie Morris, LiveScience executive editor Laura Geggel, US News & World Report reporter Susan Milligan and Voice of America senior editor Hong Xie interviewed William Schaffner, MD, professor of Preventive Medicine, for stories about the Brazilian chloroquine study and various other COVID-19 issues.

The National Foundation for Infectious Diseases (NFID) released the latest edition of "The Schaffner Report” in its recent NFID blog post. Schaffner currently serves as medial director for the NFID.

The Washington Post featured a commentary from Wes Ely, MD, MPH, professor of Medicine and Critical Care, about how ICU doctors have existing protocols to follow in order to get COVID-19 patients off ventilators faster.

National Public Radio (NPR) reporter Maria Godoy interviewed David Aronoff, MD, director, Division of Infectious Diseases, for a story about his JAMA article on safe grocery shopping.

The Wall Street Journal reporter Mark Maremont interviewed James Jackson, PsyD, assistant director of the ICU Recovery Center, for a story about the challenges ahead for COVID-19 patients once they recover from being on a ventilator.

Psychology Today posted a column written by Stephen Camarata, PhD, professor of Hearing and Speech Sciences, about supporting children with disabilities in challenging times.

BioPharma Dive senior editor Ned Pagliarulo and NPR’s 1A (WAMU 88.5) producer Avery Kleinman interviewed Wesley Self, MD, associate professor of Emergency Medicine, for stories about VUMC leading the ORCHID trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19.